Tirzepatide, a dual agonist with even stronger body weight reduction effects than semaglutide [66] reduces energy intake of approx
A., Mohs, M., Mark, L., Laczy, B., Cseh, J., et al
When combined with adequate protein intake and healthy movement, GLP-1 therapy can promote fat loss while maintaining lean muscle
Unlike other medications that target just one pathway, tirzepatide works by mimicking two essential hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Ongoing support helps you stay on track, troubleshoot setbacks, and make the most of your treatment
It showed the world that a GLP-1 receptor agonist could produce meaningful, sustained weight loss in people without diabetes